Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
D000818:Animals; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000494:pharmacology; D004247:DNA / Q000032:analysis; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006016:Glycolates / Q000494:pharmacology*; D006529:Hepatomegaly / Q000139:chemically induced; D000960:Hypolipidemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000032:analysis*; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects; D008930:Mitochondria, Liver / Q000187:drug effects; D009255:Nafenopin / Q000494:pharmacology; D010089:Oxidoreductases, N-Demethylating / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D010743:Phospholipids / Q000097:blood; D010879:Piperazines / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D011506:Proteins / Q000032:analysis; D012313:RNA / Q000032:analysis; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D014280:Triglycerides / Q000097:blood*
D006016:Glycolates; D000960:Hypolipidemic Agents; D010647:Phenyl Ethers; D010743:Phospholipids; D010879:Piperazines; D010880:Piperidines; D011422:Propionates; D011506:Proteins; D014280:Triglycerides; D009255:Nafenopin; D003609:Dactinomycin; D010672:Phenytoin; D012313:RNA; D004247:DNA; D002784:Cholesterol; D010089:Oxidoreductases, N-Demethylating; D002994:Clofibrate; D010634:Phenobarbital